Aricept (Donepezil), is a centrally acting reversible acetyl cholinesterase inhibitor. Its main therapeutic use is in the treatment of Alzheimer’s disease where it is used to increase cortical acetylcholine. Donepezil is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. If this proposed mechanism of action is correct, donepezil’s effect may lessen as the disease process advances and fewer cholinergic neurons remain functionally intact.
Related Websites - How to Find the Right Golf Shoes Having the right pair of golf shoes impacts much more than your comfort level. If you’re wearing the wrong shoes or if they do not fit properly, this can effect your swing and as such,...
- MonaVie and the Placebo Effect There are times where people will give a testimony that MonaVie helped them with [medical condition X]. I assert that it is really impossible to tell if MonaVie did that for the individual. If you...
- TSOP - An Effective Approach to Reducing Business Overhead Expenses Some small business managers across the country who have found a drop in their profits because of the downturn in the economy, are finding success in a cost reduction plan some refer to as the...
Tags: Acetyl Cholinesterase, Acetylcholine, Acetylcholinesterase, Aricept, Aricept Donepezil, Cholinergic Neurons, Cholinesterase Inhibitor, Concentration, Hydrolysis, Mechanism Of Action, Reversible Inhibition, Therapeutic Effect